DEC 2017

Epigenetics Market for Therapeutics, Research & Development - Growth, Trends and Forecasts (2017-2022)

Purchase Report
Single user license
Team license
Corporate license

Epigenetics Market for Therapeutics, Research & Development

The epigenetics market, valued as a USD 4.38 billion market in 2016, is expected to become a USD 14.32 billion market by 2021, showing a CAGR as high as 26.72%.  

Epigenetics is the study of changes in gene expression caused by certain base pairs in DNA, or RNA, being "turned off" or "turned on" again, through chemical reactions. In biology, and specifically genetics, epigenetics is mostly the study of heritable changes that are not caused by changes in the DNA sequence; to a lesser extent, epigenetics also describes the study of stable, long-term alterations in the transcriptional potential of a cell that are not necessarily heritable.

The term also refers to the changes themselves- functionally relevant changes to the genome that do not involve a change in the nucleotide sequence. Examples of mechanisms that produce such changes are DNA methylation and histone modification, each of which alters how genes are expressed without altering the underlying DNA sequence.  

Global Epigenetics Market for Therapeutics, Research & Development- Market Dynamics

The report lists several driving and restraining factors of the global epigenetics market. Some of them are listed below.


  • High incidence of cancer
  • Wide range of applications
  • Increasing investment and funds to this field of science


  • Lack of reimbursement policy
  • Lack of predictive markers

The epigenetics market is segmented on the basis of mechanism, applications, and geography. The mechanism sector can be segmented into three different categories namely DNA Methylation, RNA Interference and Histone Modifications. The application segment can again be divided into categories such as Therapeutics and Research & Diagnostics. On the basis of geography, the market is divided into North America, Europe, APAC and the Rest of the World.  

Some of the key players in the market are:

  • 4SC
  • Celgene
  • Cellcentric
  • Covaris Inc.
  • Epiontis
  • Epitherapeutics
  • Epizyme
  • Merck Millipore

Key Deliverables in the Study

  • Market analysis for the epigenetics market for therapeutics, research & development, with region-specific assessments and competition analysis on the global and regional scale.
  • Market definition along with the identification of key drivers and restraints.
  • Identification of factors instrumental in changing the market scenario, rising prospective opportunities, and identification of key companies that can influence this market on a global and regional scale.
  • Extensively researched competitive landscape section with profiles of major companies along with their market share.
  • Identification and analysis of the macro and micro factors that affect the market on both global and regional scale.
  • A comprehensive list of key market players along with the analysis of their current strategic interests and key financial information.
  • A wide-ranging knowledge and insights about the major players in this industry and the key strategies adopted by them to sustain and grow in the studied market.
  • Insights on the major countries/regions where this industry is blooming and to also identify the regions that are still untapped.
Purchase Report
Single user license
Team license
Corporate license
Our Clients Include View All

Looking to Customize Report?